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dema is caused in most cases by the obstructions 
or the stenosis of lymph vessels in relation with 
the oncological therapies1. Other causes are ac-
cidental or iatrogenic lesions of the lymphatic 
vessels.
Lymphoedema usually occurs in 6-63% of 
patients who received a radiotherapy and/or sur-
gery as cancer therapy. The rise of the pathology 
may occur immediately after this therapy or may 
be delayed2. Even if the lymphoedema does not 
represent a death risk for patients, the impact of 
the external changes in a lower quality of life is 
significative3. Lymphangiosarcoma has been de-
scribed as a rare complication, too4. Additionally, 
a very common and severe complication is cellu-
litis of the affected limb5. 
The use of penicillin is one of the most com-
mon treatments of symptomatic cellulitis; howev-
er, this is not a decisive treatment and cellulitis 
may relapse after or even during the therapy6. 
Another common treatment is drainage. Complex 
physical therapy (CPT) is a recent treatment in-
troduced for lymphoedema that reduces the limb 
circumference and the occurrence of cellulitis7,8.
The lymphaticovenular anastomosis (LVA) is a 
microsurgical technique very effective in improv-
ing limb circumference and alleviating dermal 
sclerosis9-14. 
The LVA technique rapidly evolved in recent 
years. In 2014, Yamamoto et al15 described a 
ladder-shaped LVA, 3 lymphatic vessels and 1 
vein were anastomosed in a side-to-side fashion; 
further, in 2015 Yamamoto et al16 reported the 
parachute technique, a simplified technique to 
perform the side to end supramicrosurgical lym-
phaticovenular anastomosis (s-LVA) while main-
taining efficacy comparable to the conventional 
technique.
Abstract. – OBJECTIVE: Aim of this paper is to 
present our reduction of the frequency of celluli-
tis before and after supramicrosurgical lympha-
ticovenular anastomosis (s-LVA) in lymphoede-
ma patients, and discuss the possibility to per-
form this technique outside Japan.
PATIENTS AND METHODS: 37 patients affect-
ed by lymphoedema were enrolled. All patients 
received preoperative indocyanine green lym-
phography. Under local anaesthesia s-LVA was 
performed on all patients. All patients were fol-
lowed for 1 year. Lymphoedema was staged us-
ing the lymphoedema staging classification rec-
ommended by the International Society of Lym-
phology. Cellulitis rate was recorded for all pa-
tients the year before and after the s-LVA. A 
t-test was used to evaluate differences in the fre-
quency of cellulitis the year before surgery and 
the year following surgery. 
RESULTS: Cellulitis incidence decreased in all 
patients, with a mean 1.7 cases the year before 
s-LVA and 0.1 the year after s-LVA. A significant 
difference between preoperative and postopera-
tive cellulitis rate was found (p = 0.0012).
CONCLUSIONS: This study reports our s-LVA 
case series of lymphoedema patients. With the 
proper learning curve, s-LVA may be repro-
duced and lymphoedema patients may gain a 
better quality of life and a reduced cellulitis rate.
Key Words:
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sis, LVA, Cellulitis, Lymphoedema.
Introduction
Lymphoedema is a pathology characterized by 
a limb accumulation of subcutaneous protein-rich 
fluid due to a lymphatic system disorder. While 
the primary lymphoedema is commonly caused 
by congenital abnormalities, secondary lymphoe-
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The limitation of this technique is its reproduci-
bility; commonly, mainly Japanese authors reported 
the efficacy of LVA and very few papers reported 
the effect of s-LVA on cellulitis incidence. Campisi 
et al17 in 2007 reported his experience with LVA, 
with 87% reduction of cellulitis incidence; Mihara 
et al12 in 2014 reported a significant rate of reduction 
after LVA in lymphedema patients.
The purpose of this paper is to compare the 
frequency of cellulitis before and after minimally 
invasive s-LVA in patients with arm/leg lym-
phoedema and discuss the reproducibility of this 
technique.
Patients and Methods
This is a retrospective observational study 
that reports the clinical data of preoperative and 
postoperative cellulitis rate occurred in 37 lym-
phoedema patients (M:2, F:35) operated with 
s-LVA from February 2012 to April 2013 at 
the Department of Maxillofacial Surgery, Uni-
versity of Siena, Italy. The participants signed 
an informed consent agreement. Among the 37 
patients, 10 patients presented upper limb lym-
phoedema and 27 lower limb lymphoedema. 4 
patients presented primary lymphoedema, while 
26 patients reported lymhpoedema due to breast 
cancer, and 7 patients reported lymhpoedema due 
to pelvic cancer.
The diagnostic criteria of lymphoedema were 
based on indocyanine green (ICG) lymphography 
findings, clinical criteria, lymphoscintigraphy as 
well as limb circumference18-21. Lymphoedema 
was staged using the lymphoedema staging clas-
sification recommended by the International So-
ciety of Lymphology.
The diagnostic criteria for cellulitis were a 
fever of 38.5°C or higher and warmth/redness in 
the affected limb.
Lymphography was performed with two injec-
tions with green indocyanine (Pulsion®) between 
first and second, fourth and fifth toes of the limb; 
a superficial vein mapping with Accuvein device 
was performed before surgery too.
Surgical Technique
Under local anaesthesia with 1% adrenaline 
xylocaine, a skin incision was performed for 
each site. The subcutaneous tissue was dissected 
under a high magnification operating micro-
scope. Lymphatic collectors and adjacent sub-
cutaneous veins were identified. Vessels were 
dissected and 4 or 5 11/0 endoluminal sutures 
with a 50-micron needle were performed (Fig-
ure 1). After each anastomosis, the milk-test 
was performed to check the patency22 (Figure 2). 
Afterwards, the skin was sutured with continu-
Figure 1. Image of an anastomosis between a lymphatic of 
approximately 0.5 mm diameter (at the top) and a venule of the 
same size. Inside the anastomosis a stent made with 7/0 ethilon 
suture was present: this stent was used to ensure the patency 
of the anastomosis and removed before the last suture. This 
lambda-shaped anostomosis allows efficient lymphaticovenu-
lar anastomoses to be performed simultaneously by a team of 
surgeons, resulting in an increased number of bypasses22.
Figure 2. Intraoperative figure after s-LVA with milk-test per-
formance: milk-test evaluates the patency of the anostomosis.
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ous 6/0 absorbable microsutures. The purpose 
of this technique was to drain the accumulated 
lymphatic fluid into the venous system. The 
anastomotic configuration was chosen on the 
basis of the vessels calibre; the most performed 
was the end-to-end configuration, while the 
side-to-end configuration was performed if the 
venular calibre was twice the lymphatic vessel 
calibre23. The average number of anastomosis 
performed was 3 per patient, with an average 
operation time of 3 hours.
The incidence of cellulitis before surgery was 
recorded in the patient history collection, while 
postoperative cellulitis was collected with tele-
phone interviews.
Standardized CPT with compression garments 
was performed 1 year before surgery with 20 
cycles of therapy with lymphatic drainages, fol-
lowed by bandage with progressive compression; 
two weeks after s-LVA CPT was continued post-
operatively for 1 year. Oral amoxicillin (1 g) was 
prescribed for 2 days after s-LVA.
The evaluated parameters consisted in: age at 
the time of surgery, sex, radiotherapy, affected 
limb, lymphoedema stage, time of lymphoede-
ma before surgery, follow-up period, number of 
cellulitis occurred in the year before surgery, 
number of cellulitis after surgery.
The frequency of cellulitis in the year be-
fore and after s-LVA was compared.
Statistical Analysis
The t-test was used to evaluate if the de-
crease of cellulitis was significant. If not 
otherwise specified two-tailed p-values < 0.05 
were considered significant.
Results
S-LVA resulted successful in all patients as 
the intraoperative wash-out of the LVA resulted 
positive in all patients. Table I reports popula-
tion data of the patients. The incidence of cellu-
litis significantly decreased in all patients; pass-
ing from an average of 1.7 cases the year before 
s-LVA to 0.1 the year after surgery (p = .0012). 
Cellulitis incidence in upper limb lymphedema 
dropped from an average of 1.4 cases the year 
before s-LVA to 0.07 cases the year after surgery 
while in lower limb lymphedema cellulitis inci-
dence decreased from an average of 2.8 cases 
the year before s-LVA to 0.2 cases the year after 
surgery. All patients with ISL stage 1, 2a and 
3 showed a reduction of cellulitis incidence to 
zero cases the year after LVA while 2b ISL stage 
patients showed a cellulitis incidence decreased 
from an average of 3.3 the year before s-LVA to 
an average of 0.3 the year after surgery. s-LVA 
appeared to reduce the instances of cellulitis on 
all patients. Two typical cases are reported in 
Figure 3 and Figure 4.
Discussion
Cellulitis is a very serious episode that de-
grades the quality of life of many patients. Every 
Table I.This table shows the p-values of patients before and after LVA, and patients characteristics. Two-tailed p-values of <0.05 
were considered significant if not otherwise specified.
Patient characteristics Number Mean number of  Mean number of
   lymphangitis in the  lymphangitis in the
   year before LVA year after LVA*
Total 37 1.7 0.1
Location                     upper limb 10 1.4 0.07
                                   lower limb 27 2.8 0.2
ISL stage                   1 11 0.3 0
ISL stage                   2a 11 1.9 0
ISL stage                   2b 13 3.3 0.3
ISL stage                   3 2 2.5 0
Aetiology                   primary 4 3.8 0
                                   secondary 33 1.5 0.1
Cause                         pelvic cancer 7 1.8 0.3
                                   breast cancer 26 1.5 0.1
Radiotherapy            yes 24 1.6 0.1
                                  no 13 2.8 0.2
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fibrosis, leading to a vicious cycle where the lym-
phoedema worsens and cellulitis becomes easier 
and easier to develop24. 
Minimizing the lymphoedema progression 
is required in order to prevent and reduce the 
frequency of cellulitis. LVA has proven its re-
liability in reducing the incidence of cellulitis, 
as recently reported by Mihara et al12. Campisi 
et al25 reported good results with LVA, too. 
Onoda et al26 reported satisfactory results in 
the reduction of cellulitis in lymphoedema 
patients with LVA, and Boccardo et al27 re-
ported a positive outcome with the use of the 
LYMPHA method.
All papers that report the role of s-LVA in 
lymphoedema patients are usually Japanese pa-
pers; the main argument against this technique 
is its difficult reproducibility out of Japan.
In the present study, we performed s-LVA on 
37 Italian patients and reduced cellulitis inci-
dence from an average of 1.7 episodes per year 
before s-LVA to an average of 0.1 cases per year 
after s-LVA. Patient with 2a and 2b ISL stage 
reported the most marked decrease.
The traditional LVA technique uses lymphatic 
vessels at the root of the limb, while s-LVA con-
sists in a supramicrosurgical endoluminal anas-
tomosis performed on small veins with 0.2 mm 
diameter all over the limb; with s-LVA smaller 
Figure 3. Clinical appearance of right lower limb before 
(A) and after (B) s-LVA. This patient reported lymphedema 
of the lower right limb after ovarian cancer surgery; after the 
s-LVA the limb circumference reduced and no cellulitis were 
reported in the year after s-LVA.
Figure 4. Clinical appearance of a upper limb in a lymphoedema case after the s-LVA (A). Clinical appearance before s-LVA 
(B).This patient reported lymphedema after breast cancer surgery, with numerous cellulitis: after s-LVA the limb circumference 
reduced and no cellulitis were reported in the year after s-LVA.
case damages the lymphatic vessels and may 
worsen the lymphoedema. Lymph vessels and 
subcutaneous tissue undergo to cellulitis-induced 
P. Gennaro, G. Gabriele, C. Salini, G. Chisci, F. Cascino, J.-F. Xu, C. Ungari
678
 
lymphatic vessels may be detected and used 
for the supramicrosurgical anastomosis with 
smaller veins.
S-LVA reduces cellulitis rate in lymphoedema 
patients due to the formation of anastomosis and 
lets the lymph flow into the peripheral venular 
circulation, with a reduction of stagnant lymph. 
The concomitant use of CPT and s-LVA with 
their different mechanisms may also have a syn-
ergistic effect on improving lymphatic stasis.
A standard prophylaxis protocol for cellulitis 
in lymphoedema patients is yet to be present in 
literature; s-LVA may play an important role in 
the prevention of future cellulitis cases after can-
cer surgery and/or radiotherapy.
In this study, we report a consistent number 
of lymphoedema patients operated in Italy with 
s-LVA. This paper dispels the myth of an irre-
producible technique and opens the gates for a 
worldwide dissemination of the technique as the 
reported results similar to Mihara et al12 suggest 
the possibility of diffusion of this technique.
S-LVA is a standardized, reliable and repro-
ducible technique that finds its main indication in 
lymphoedema treatment. The reduction of celluli-
tis in these patients after s-LVA adds credit to this 
technique while validating it.
The recent introduction of ICG lymphography 
and the possibility to perform the LVA operation 
via the supramicrosurgical technique and under 
local anesthesia makes this a minimally invasive 
approach10. ICG lymphography is a useful imag-
ing technique for both beginner and advanced mi-
crosurgeon to investigate lymphatic disorders and 
to decide the best sites for skin incisions. Even 
though the number of patients in this study was 
relatively small, a positive trend was evidenced in 
all subclasses reported in Table I. Further, in pa-
tients with prolonged follow-up (2 years), the cel-
lulitis trend kept going towards even lower rates.
The limitation of the present study is repre-
sented by the fact that it is a retrospective study 
and no consideration was given to the volume 
reduction. Our study group is now working to 
another article with a greater population focused 
on limb volume reduction after s-LVA28.
Conclusions
A significant reduction of cellulitis after s-LVA 
was reported in all patients enrolled in this study. 
S-LVA is a standardized, minimally invasive and 
easily accepted by patients operation that influ-
ences the incidence of cellulitis in lymphedema 
patients. The main argument against s-LVA in 
lymphoedema patients is that the positive results 
present in literature come only from Japanese 
microsurgeons. This paper reports similar results 
out of Japan, suggesting the possibility of diffu-
sion of this technique.
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